Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for PACB

Stock NamePacific Biosciences of California
TickerPACB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS69404D1081

Show aggregate PACB holdings

News associated with PACB

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of “Hold” from Brokerages
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given a consensus recommendation of “Hold” by the eight analysts that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The […] - 2025-08-11 05:18:54
XTX Topco Ltd Takes $576,000 Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
XTX Topco Ltd bought a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 488,237 shares of the biotechnology company’s stock, valued at approximately $576,000. XTX Topco Ltd owned […] - 2025-08-07 04:58:54
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Acquired by Wealthfront Advisers LLC
Wealthfront Advisers LLC raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 137.3% in the 1st quarter, HoldingsChannel.com reports. The fund owned 89,576 shares of the biotechnology company’s stock after buying an additional 51,825 shares during the quarter. Wealthfront Advisers LLC’s holdings in Pacific Biosciences of California were […] - 2025-07-23 05:53:08
Teacher Retirement System of Texas Invests $43,000 in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Teacher Retirement System of Texas acquired a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 36,528 shares of the biotechnology company’s stock, valued at approximately $43,000. Other institutional investors also recently added to […] - 2025-07-22 04:14:57
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Rating of “Hold” by Brokerages
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been given an average recommendation of “Hold” by the nine research firms that are presently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average […] - 2025-07-22 03:29:05
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. trimmed its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,565,331 shares of the biotechnology company’s stock after selling 613,170 […] - 2025-07-04 05:16:50
Barclays Has Lowered Expectations for Pacific Biosciences of California (NASDAQ:PACB) Stock Price
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price target cut by investment analysts at Barclays from $2.00 to $1.50 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biotechnology company’s stock. Barclays‘s price objective points to a potential upside of 16.28% […] - 2025-06-27 02:42:44
Pacific Biosciences Of California To Present At Jefferies Conference; Webcast At 8:45 AM ET
(RTTNews) - Pacific Biosciences of California, Inc. (PACB) will present at Jefferies Healthcare Conference in . - 2025-06-05 08:45:26
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […] - 2025-05-28 04:46:51
Cresset Asset Management LLC Sells 40,890 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Cresset Asset Management LLC cut its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 61.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,883 shares of the biotechnology company’s stock after selling 40,890 shares during […] - 2025-05-19 05:04:57
Raymond James Financial Inc. Invests $253,000 in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Raymond James Financial Inc. purchased a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 138,116 shares of the biotechnology company’s stock, valued at approximately $253,000. A number of other large investors also recently modified their holdings of the business. ARK Investment Management […] - 2025-05-12 04:22:50
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.45 Average PT from Brokerages
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average […] - 2025-05-06 02:30:47
Legal & General Group Plc Lowers Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Legal & General Group Plc lessened its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 234,635 shares of the biotechnology company’s stock after selling 16,736 shares […] - 2025-04-30 05:31:02
Geode Capital Management LLC Sells 64,981 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Geode Capital Management LLC lowered its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 1.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 6,262,925 shares of the biotechnology company’s stock after selling 64,981 shares during the quarter. Geode Capital Management LLC’s holdings in Pacific Biosciences of California […] - 2025-04-23 04:26:51
Cibc World Markets Corp Makes New Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Cibc World Markets Corp acquired a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,600 shares of the biotechnology company’s stock, valued at approximately $47,000. […] - 2025-03-28 06:18:45
Pacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.00 by Analysts at Scotiabank
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biotechnology company’s stock. Scotiabank’s price target points to a potential upside of 57.48% from the […] - 2025-03-27 04:46:50
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by New York State Common Retirement Fund
New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 299.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,725 shares of the biotechnology company’s stock after purchasing […] - 2025-03-06 08:56:56
Pacific Biosciences of California Sees Unusually High Options Volume (NASDAQ:PACB)
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors acquired 31,944 call options on the stock. This represents an increase of approximately 477% compared to the typical volume of 5,533 call options. Wall Street Analyst Weigh In Several analysts have recently weighed […] - 2025-02-20 05:11:07

iShares Healthcare Innovation UCITS ETF USD (Acc) PACB holdings

DateNumber of PACB Shares HeldBase Market Value of PACB SharesLocal Market Value of PACB SharesChange in PACB Shares HeldChange in PACB Base ValueCurrent Price per PACB Share HeldPrevious Price per PACB Share Held
2025-11-11 (Tuesday)371,114USD 690,272USD 690,272
2025-11-10 (Monday)371,114USD 653,161USD 653,1610USD 0 USD 1.76 USD 1.76
2025-11-07 (Friday)371,114USD 653,161PACB holding decreased by -7422USD 653,1610USD -7,422 USD 1.76 USD 1.78
2025-11-06 (Thursday)371,114USD 660,583PACB holding decreased by -50100USD 660,5830USD -50,100 USD 1.78 USD 1.915
2025-11-05 (Wednesday)371,114USD 710,683PACB holding decreased by -31545USD 710,6830USD -31,545 USD 1.915 USD 2
2025-11-04 (Tuesday)371,114USD 742,228PACB holding decreased by -89067USD 742,2280USD -89,067 USD 2 USD 2.24
2025-11-03 (Monday)371,114USD 831,295PACB holding decreased by -37112USD 831,2950USD -37,112 USD 2.24 USD 2.34
2025-10-31 (Friday)371,114USD 868,407PACB holding increased by 148446USD 868,4070USD 148,446 USD 2.34 USD 1.94
2025-10-30 (Thursday)371,114USD 719,961PACB holding decreased by -25978USD 719,9610USD -25,978 USD 1.94 USD 2.01
2025-10-29 (Wednesday)371,114USD 745,939PACB holding increased by 14844USD 745,9390USD 14,844 USD 2.01 USD 1.97
2025-10-28 (Tuesday)371,114USD 731,095PACB holding decreased by -44533USD 731,0950USD -44,533 USD 1.97 USD 2.09
2025-10-27 (Monday)371,114USD 775,628PACB holding increased by 25978USD 775,6280USD 25,978 USD 2.09 USD 2.02
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PACB by Blackrock for IE00BYZK4776

Show aggregate share trades of PACB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-3,1862.0202.080 2.074USD -6,608 1.46 Loss of -1,953 on sale
2025-09-11BUY1,6291.2601.270 1.269USD 2,067 1.46
2025-07-08SELL-1,5941.5001.500 1.500USD -2,391 1.46 Loss of -67 on sale
2025-06-24SELL-1,6501.2001.220 1.218USD -2,010 1.46 Profit of 405 on sale
2025-06-23SELL-1,6501.1901.270 1.262USD -2,082 1.47 Profit of 336 on sale
2025-06-20BUY53,0981.2701.340 1.333USD 70,780 1.47
2025-06-11SELL-1,4101.1601.220 1.214USD -1,712 1.48 Profit of 372 on sale
2025-05-30SELL-1,4160.9601.040 1.032USD -1,461 1.50 Profit of 669 on sale
2025-05-21BUY1,4220.9801.020 1.016USD 1,445 1.54
2025-05-14SELL-8,4301.1001.150 1.145USD -9,652 1.55 Profit of 3,454 on sale
2025-04-30SELL-1,3961.1101.120 1.119USD -1,562 1.60 Profit of 667 on sale
2025-04-28SELL-1,3991.1301.150 1.148USD -1,606 1.61 Profit of 642 on sale
2025-04-25SELL-1,3931.0901.150 1.144USD -1,594 1.61 Profit of 652 on sale
2025-04-11SELL-8,6221.3601.390 1.387USD -11,959 1.65 Profit of 2,251 on sale
2025-04-08SELL-4,2691.2001.370 1.353USD -5,776 1.66 Profit of 1,305 on sale
2025-04-07SELL-2,9921.3201.390 1.383USD -4,138 1.66 Profit of 836 on sale
2025-03-31SELL-2,8501.1801.190 1.189USD -3,389 1.69 Profit of 1,414 on sale
2025-03-21SELL-2,8081.3001.300 1.300USD -3,650 1.72 Profit of 1,174 on sale
2025-03-12SELL-1,4521.2801.370 1.361USD -1,976 1.77 Profit of 589 on sale
2025-02-28SELL-1,4441.4501.480 1.477USD -2,133 1.82 Profit of 498 on sale
2025-02-25BUY1,4491.5601.660 1.650USD 2,391 1.84
2025-02-20SELL-1,4341.6401.860 1.838USD -2,636 1.85 Profit of 15 on sale
2025-02-19BUY2,8621.7701.950 1.932USD 5,529 1.85
2025-02-18BUY1,4311.8702.010 1.996USD 2,856 1.85
2024-12-30SELL-2,7151.7901.850 1.844USD -5,006 2.01 Profit of 441 on sale
2024-12-06SELL-1,3622.0302.130 2.120USD -2,887 1.99 Loss of -179 on sale
2024-12-04SELL-1,3652.0802.140 2.134USD -2,913 1.99 Loss of -202 on sale
2024-12-03SELL-2,7421.8301.910 1.902USD -5,215 1.99 Profit of 246 on sale
2024-11-21SELL-1,4251.7701.840 1.833USD -2,612 2.06 Profit of 330 on sale
2024-11-20SELL-1,4981.7201.780 1.774USD -2,657 2.08 Profit of 464 on sale
2024-11-19SELL-1,4981.7201.750 1.747USD -2,617 2.11 Profit of 536 on sale
2024-11-18SELL-5,5721.5701.690 1.678USD -9,350 2.14 Profit of 2,566 on sale
2024-11-12SELL-1,3822.2102.660 2.615USD -3,614 2.13 Loss of -665 on sale
2024-11-07SELL-1,3792.4502.720 2.693USD -3,714 2.10 Loss of -822 on sale
2024-11-05SELL-2,7582.5502.650 2.640USD -7,281 2.01 Loss of -1,750 on sale
2024-10-28SELL-1,3941.8401.860 1.858USD -2,590 1.78 Loss of -114 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PACB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,637,3167,0703,271,66850.0%
2025-09-181,513,9462,1982,814,65453.8%
2025-09-171,976,1471,0003,306,26459.8%
2025-09-161,104,239104,486,15424.6%
2025-09-152,088,227514,050,48151.6%
2025-09-123,967,06450,8445,144,55377.1%
2025-09-111,008,7396,7322,352,59642.9%
2025-09-101,590,7187,9192,755,79257.7%
2025-09-09937,89239,3131,922,24148.8%
2025-09-08569,1262,4701,144,00449.7%
2025-09-05768,8937,2831,934,98439.7%
2025-09-041,640,6579192,924,61356.1%
2025-09-03740,0474,0291,219,32160.7%
2025-09-021,211,1507,8561,879,08864.5%
2025-08-291,143,1131,0161,574,68572.6%
2025-08-28834,90351,323,58263.1%
2025-08-27727,71010,9171,689,70543.1%
2025-08-261,066,5052,1001,793,89359.5%
2025-08-251,018,8124431,839,04855.4%
2025-08-221,134,77913,4993,200,64535.5%
2025-08-211,494,82713,7002,428,94261.5%
2025-08-201,139,65012,4121,651,03069.0%
2025-08-192,207,01049,4923,074,83071.8%
2025-08-181,418,3671,1492,161,86465.6%
2025-08-152,461,2157614,524,78754.4%
2025-08-144,064,5376,3445,716,95371.1%
2025-08-134,864,5866347,672,02463.4%
2025-08-123,172,56314,3184,456,58071.2%
2025-08-113,343,8642,9664,759,82470.3%
2025-08-084,179,4625005,916,04470.6%
2025-08-072,501,72210,1023,980,73362.8%
2025-08-061,416,5213,5412,404,16558.9%
2025-08-051,272,8202,1702,258,00056.4%
2025-08-042,120,8605,3103,154,17067.2%
2025-08-012,101,35412,7423,892,98354.0%
2025-07-312,449,21510,5863,984,58461.5%
2025-07-301,448,4308,1092,449,34159.1%
2025-07-292,538,9163,2764,239,92359.9%
2025-07-282,049,7826,1374,429,08846.3%
2025-07-251,844,10598,0932,833,21665.1%
2025-07-241,795,32220,2363,233,68455.5%
2025-07-231,901,26513,8456,743,47928.2%
2025-07-221,783,24318,0445,392,95433.1%
2025-07-212,446,2291,4015,190,01747.1%
2025-07-181,346,50617,9502,299,98858.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.